Evolutionary dynamics of tumor suppressor gene inactivation.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMC 489986)

Published in Proc Natl Acad Sci U S A on July 13, 2004

Authors

Martin A Nowak1, Franziska Michor, Natalia L Komarova, Yoh Iwasa

Author Affiliations

1: Program for Evolutionary Dynamics, Harvard University, Cambridge, MA 02138, USA. martin_novak@harvard.edu

Articles citing this

Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A (2010) 4.47

Deterministic and stochastic regimes of asexual evolution on rugged fitness landscapes. Genetics (2006) 1.28

Efficiency of carcinogenesis with and without a mutator mutation. Proc Natl Acad Sci U S A (2006) 1.25

The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. Proc Natl Acad Sci U S A (2006) 1.17

Selection in spatial stochastic models of cancer: migration as a key modulator of fitness. Biol Direct (2010) 1.17

Examples of mathematical modeling: tales from the crypt. Cell Cycle (2007) 1.11

Evolution of mutational robustness in the yeast genome: a link to essential genes and meiotic recombination hotspots. PLoS Genet (2009) 1.11

Age-specific incidence of inherited versus sporadic cancers: a test of the multistage theory of carcinogenesis. Proc Natl Acad Sci U S A (2005) 1.09

The pace of evolution across fitness valleys. J Theor Biol (2009) 1.04

Cancer: looking for simplicity and finding complexity. Cancer Cell Int (2006) 1.01

Genetic instability and clonal expansion. J Theor Biol (2006) 1.00

Dynamics of mutant cells in hierarchical organized tissues. PLoS Comput Biol (2011) 0.99

Do mutator mutations fuel tumorigenesis? Cancer Metastasis Rev (2013) 0.96

Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy. PLoS Comput Biol (2015) 0.96

Mutator mutations enhance tumorigenic efficiency across fitness landscapes. PLoS One (2009) 0.90

The effect of one additional driver mutation on tumor progression. Evol Appl (2012) 0.90

Bioinformatics for cancer immunology and immunotherapy. Cancer Immunol Immunother (2012) 0.90

In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation? Nat Rev Cancer (2013) 0.89

Peto's paradox revisited: theoretical evolutionary dynamics of cancer in wild populations. Evol Appl (2012) 0.87

Riparian ecosystems in human cancers. Evol Appl (2012) 0.85

Programmed genetic instability: a tumor-permissive mechanism for maintaining the evolvability of higher species through methylation-dependent mutation of DNA repair genes in the male germ line. Mol Biol Evol (2008) 0.84

Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis. J Theor Biol (2010) 0.84

Population genetics of cancer cell clones: possible implications of cancer stem cells. Theor Biol Med Model (2010) 0.84

Inter-cellular signaling network reveals a mechanistic transition in tumor microenvironment. Integr Biol (Camb) (2012) 0.83

Genetic instability in gastric epithelial neoplasias categorized by the revised vienna classification. Gut Liver (2010) 0.80

Spatial invasion dynamics on random and unstructured meshes: implications for heterogeneous tumor populations. J Theor Biol (2014) 0.80

The fastest evolutionary trajectory. J Theor Biol (2007) 0.80

Spatial Moran Models I. Stochastic Tunneling in the Neutral Case. Ann Appl Probab (2015) 0.79

Modeling Invasion Dynamics with Spatial Random-Fitness Due to Micro-Environment. PLoS One (2015) 0.77

Stochastic Tunneling of Two Mutations in a Population of Cancer Cells. PLoS One (2013) 0.77

Mathematical models for translational and clinical oncology. J Clin Bioinforma (2013) 0.77

A deterministic analysis of genome integrity during neoplastic growth in Drosophila. PLoS One (2014) 0.77

Stochastic tunneling and metastable states during the somatic evolution of cancer. Genetics (2015) 0.75

A systems approach defining constraints of the genome architecture on lineage selection and evolvability during somatic cancer evolution. Biol Open (2012) 0.75

Articles cited by this

Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A (1971) 31.05

Genetic instabilities in human cancers. Nature (1998) 22.76

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96

Genetic instability in colorectal cancers. Nature (1997) 12.51

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (1983) 11.57

Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science (1991) 6.15

Tumor suppressor genes. Science (1991) 5.72

Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst (1981) 5.59

Two genetic hits (more or less) to cancer. Nat Rev Cancer (2001) 5.19

Maintenance of genome stability in Saccharomyces cerevisiae. Science (2002) 5.08

Segregating sister genomes: the molecular biology of chromosome separation. Science (2002) 4.92

Connecting chromosomes, crisis, and cancer. Science (2002) 4.69

Errors in DNA replication as a basis of malignant changes. Cancer Res (1974) 4.60

A mutator phenotype in cancer. Cancer Res (2001) 4.41

Antioncogenes and human cancer. Proc Natl Acad Sci U S A (1993) 4.09

Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A (2002) 3.64

The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci U S A (2002) 3.46

The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer (2003) 3.21

The tumor suppressor genes. Annu Rev Biochem (1993) 3.12

The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med (1999) 2.76

The mutation rate and cancer. Proc Natl Acad Sci U S A (1996) 2.73

Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res (2003) 2.68

Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res (2001) 2.65

Dynamics of cancer progression. Nat Rev Cancer (2004) 2.64

Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat (1993) 2.63

Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res (1995) 2.35

Genomic instability--the engine of tumorigenesis? Nat Rev Cancer (2003) 2.27

Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology (2002) 1.91

Dynamics of genetic instability in sporadic and familial colorectal cancer. Cancer Biol Ther (2003) 1.89

Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. J Theor Biol (2003) 1.87

The linear process of somatic evolution. Proc Natl Acad Sci U S A (2003) 1.66

Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. Proc Natl Acad Sci U S A (1999) 1.45

Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. Proc Natl Acad Sci U S A (2002) 1.36

Intestinal adenomas can develop with a stable karyotype and stable microsatellites. Proc Natl Acad Sci U S A (2002) 1.30

Local regulation of homeostasis favors chromosomal instability. Curr Biol (2003) 1.02

Articles by these authors

Antibody neutralization and escape by HIV-1. Nature (2003) 21.48

Dynamics of chronic myeloid leukaemia. Nature (2005) 6.63

A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature (2011) 5.78

Computational and evolutionary aspects of language. Nature (2002) 5.39

Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling. Sci Transl Med (2011) 4.91

Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest (2010) 4.22

Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med (2004) 3.48

The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci U S A (2002) 3.46

Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell (2012) 3.39

Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease. J Clin Oncol (2013) 2.90

How should we define goodness?--reputation dynamics in indirect reciprocity. J Theor Biol (2004) 2.81

Dynamics of cancer progression. Nat Rev Cancer (2004) 2.64

DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes. Nat Biotechnol (2011) 2.62

Synergy and discounting of cooperation in social dilemmas. J Theor Biol (2005) 2.49

Stochastic tunnels in evolutionary dynamics. Genetics (2004) 2.42

Evolution of resistance during clonal expansion. Genetics (2006) 2.36

The leading eight: social norms that can maintain cooperation by indirect reciprocity. J Theor Biol (2005) 2.26

Evolutionary pathways in BRCA1-associated breast tumors. Cancer Discov (2012) 2.01

Genetic and phenotypic diversity in breast tumor metastases. Cancer Res (2014) 1.96

A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc Natl Acad Sci U S A (2010) 1.81

Successful therapy must eradicate cancer stem cells. Stem Cells (2006) 1.78

The coevolution of altruism and punishment: role of the selfish punisher. J Theor Biol (2005) 1.78

Evolutionary dynamics of invasion and escape. J Theor Biol (2004) 1.78

Can chromosomal instability initiate tumorigenesis? Semin Cancer Biol (2005) 1.77

Indirect reciprocity provides only a narrow margin of efficiency for costly punishment. Nature (2009) 1.70

The linear process of somatic evolution. Proc Natl Acad Sci U S A (2003) 1.66

Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes. Blood (2014) 1.64

DNA secondary structures and epigenetic determinants of cancer genome evolution. Nat Struct Mol Biol (2011) 1.56

The evolution of two mutations during clonal expansion. Genetics (2007) 1.52

Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin Cancer Res (2012) 1.51

Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. PLoS Genet (2013) 1.50

Dynamics of colorectal cancer. Semin Cancer Biol (2005) 1.50

Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies. PLoS Comput Biol (2009) 1.43

Evolutionary theory of cancer. Ann N Y Acad Sci (2009) 1.41

Global analyses of evolutionary dynamics and exhaustive search for social norms that maintain cooperation by reputation. J Theor Biol (2006) 1.41

DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood (2011) 1.40

Evolutionary dynamics of escape from biomedical intervention. Proc Biol Sci (2003) 1.38

(A)symmetric stem cell replication and cancer. PLoS Comput Biol (2007) 1.36

A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep (2013) 1.33

Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia. PLoS One (2011) 1.32

Mathematical models of specificity in cell signaling. Biophys J (2007) 1.31

Intratumor heterogeneity in evolutionary models of tumor progression. Genetics (2011) 1.31

DNA replication timing and higher-order nuclear organization determine single-nucleotide substitution patterns in cancer genomes. Nat Commun (2013) 1.30

Population genetics of tumor suppressor genes. J Theor Biol (2004) 1.27

Genetic addiction: selfish gene's strategy for symbiosis in the genome. Genetics (2005) 1.27

Linear model of colon cancer initiation. Cell Cycle (2004) 1.26

Evolution of the cancer genome. Trends Genet (2012) 1.22

Effects of pharmacokinetic processes and varied dosing schedules on the dynamics of acquired resistance to erlotinib in EGFR-mutant lung cancer. J Thorac Oncol (2012) 1.22

Symmetric vs. asymmetric stem cell divisions: an adaptation against cancer? PLoS One (2013) 1.18

The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. Proc Natl Acad Sci U S A (2006) 1.17

Evolution of resistance to cancer therapy. Curr Pharm Des (2006) 1.17

Selection in spatial stochastic models of cancer: migration as a key modulator of fitness. Biol Direct (2010) 1.17

Stochastic elimination of cancer cells. Proc Biol Sci (2003) 1.16

Evolution of resistance to anti-cancer therapy during general dosing schedules. J Theor Biol (2009) 1.15

Patterns of cell division and the risk of cancer. Genetics (2003) 1.15

Evolutionary dynamics of feedback escape and the development of stem-cell-driven cancers. Proc Natl Acad Sci U S A (2011) 1.14

Comment on "Extinction debt and windows of conservation opportunity in the Brazilian Amazon". Science (2013) 1.14

Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell (2013) 1.14

Evolutionary dynamics of intratumor heterogeneity. PLoS One (2011) 1.14

A progenitor cell origin of myeloid malignancies. Proc Natl Acad Sci U S A (2009) 1.12

A model for the circadian rhythm of cyanobacteria that maintains oscillation without gene expression. Biophys J (2006) 1.10

Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer. Mol Pharm (2011) 1.10

Neutral theory as a predictor of avifaunal extinctions after habitat loss. Proc Natl Acad Sci U S A (2011) 1.08

A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis. PLoS Comput Biol (2012) 1.07

Stochastic dynamics of metastasis formation. J Theor Biol (2005) 1.07

Saturation of enzyme kinetics in circadian clock models. J Biol Rhythms (2002) 1.05

Evolutionary dynamics of tumor progression with random fitness values. Theor Popul Biol (2010) 1.05

Somatic selection for and against cancer. J Theor Biol (2003) 1.05

Stripes, spots, or reversed spots in two-dimensional Turing systems. J Theor Biol (2003) 1.05

Dynamics of metastasis suppressor gene inactivation. J Theor Biol (2006) 1.04

Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. PLoS Comput Biol (2009) 1.04

The pace of evolution across fitness valleys. J Theor Biol (2009) 1.04

Comparative study of circadian clock models, in search of processes promoting oscillation. J Theor Biol (2002) 1.04

Next-generation sequencing of paired tyrosine kinase inhibitor-sensitive and -resistant EGFR mutant lung cancer cell lines identifies spectrum of DNA changes associated with drug resistance. Genome Res (2013) 1.03

Early infection and spread of a conditionally replicating adenovirus under conditions of plaque formation. Virology (2011) 1.02

The evolution of a Müllerian mimic in a spatially distributed community. J Theor Biol (2005) 1.02

Local regulation of homeostasis favors chromosomal instability. Curr Biol (2003) 1.02

Complex spatial dynamics of oncolytic viruses in vitro: mathematical and experimental approaches. PLoS Comput Biol (2012) 1.02

Optimizing combination therapies with existing and future CML drugs. PLoS One (2010) 1.01

The worst drug rule revisited: mathematical modeling of cyclic cancer treatments. Bull Math Biol (2010) 1.01

Genetic instability and clonal expansion. J Theor Biol (2006) 1.00

How canalization can make loops: a new model of reticulated leaf vascular pattern formation. J Theor Biol (2006) 1.00

The therapeutic implications of plasticity of the cancer stem cell phenotype. PLoS One (2010) 0.99

Evolution towards oscillation or stability in a predator-prey system. Proc Biol Sci (2010) 0.99

A differentiation-based phylogeny of cancer subtypes. PLoS Comput Biol (2010) 0.98

Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells. Blood (2011) 0.98

A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy. Am J Pathol (2010) 0.97

Dependence of the firearm-related homicide rate on gun availability: a mathematical analysis. PLoS One (2013) 0.96

A symmetry of fixation times in evoultionary dynamics. J Theor Biol (2006) 0.95

Optimal growth pattern of defensive organs: the diversity of shell growth among mollusks. Am Nat (2004) 0.95

Tumor growth dynamics: insights into evolutionary processes. Trends Ecol Evol (2013) 0.95

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. Cancer Med (2014) 0.95

Genetic instability and the quasispecies model. J Theor Biol (2006) 0.94

Coupled ecological-social dynamics in a forested landscape: spatial interactions and information flow. J Theor Biol (2007) 0.94

Growth based morphogenesis of vertebrate limb bud. Bull Math Biol (2008) 0.93